Outcome of Kasai Portoenterostomy in Biliary Atresia in Upper Egypt
NCT ID: NCT05925543
Last Updated: 2023-06-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
45 participants
OBSERVATIONAL
2019-01-01
2019-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Inclusion and exclusion criteria
Inclusion criteria included all neonates diagnosed with biliary atresia in the previous period and managed by Kasai portoenterostomy.
Exclusion criteria were neonates without a confirmed diagnosis of biliary atresia.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
all neonates diagnosed with biliary atresia and managed by Kasai portoenterostomy.
all neonates diagnosed with biliary atresia in the previous period 2019 and managed by Kasai portoenterostomy.
Kasai portoenterostomy operation.
Kasai portoenterostomy operation for biliary atresia patients.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Kasai portoenterostomy operation.
Kasai portoenterostomy operation for biliary atresia patients.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
4 Weeks
19 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aswan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sarah Magdy Abdelmohsen
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah Abdelmohsen, Md
Role: PRINCIPAL_INVESTIGATOR
Aswan University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aswan university Hospital
Aswān, Aswan Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Aswan UH7
Identifier Type: -
Identifier Source: org_study_id